IFNL3 and hepatocellular carcinoma: In the presented study, we aimed to elucidate how expression of the putative oncoprotein UCKL-1 in the liver together with IL28B polymorphism might be associated with HCC manifestation and progression in cirrhotic CHC patients, with the expectation of a synergistic effect between these markers in HCC pathology.